tiprankstipranks
Evelo Biosciences Inc (EVLO)
OTHER OTC:EVLO
US Market
EVLO
Evelo Biosciences
RESEARCH TOOLSreports
Want to see EVLO full AI Analyst Report?

Evelo Biosciences (EVLO) Income Statement

211 Followers

Evelo Biosciences Income Statement

Last quarter (Q3 2023), Evelo Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Evelo Biosciences's net income was $-12.36M. See Evelo Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 108.47M$ 115.40M$ 91.89M$ 86.36M$ 58.10M
Depreciation and Amortization
$ 2.06M$ 2.22M$ 2.03M$ 1.76K$ 1.94K
EBITDA
$ -106.34M$ -115.40M$ -89.86M$ -84.42M$ -58.10M
Operating Income
$ -108.47M$ -115.40M$ -91.89M$ -86.36M$ -58.10M
Other Income/Expenses
$ -5.13M$ -6.35M$ -1.37M$ 885.00K$ 1.16M
Pretax Income
$ -113.60M$ -121.75M$ -93.26M$ -85.47M$ -56.95M
Net Income
$ -114.53M$ -122.18M$ -93.67M$ -85.66M$ -53.85M
Per Share Metrics
Basic EPS
$ -26.28$ -46.18$ -47.45$ -53.49$ -49.25
Diluted EPS
$ -26.28$ -46.18$ -47.45$ -53.49$ -49.25
Weighted Average Shares Outstanding
 4.36M 2.65M 1.97M 1.60M 1.09M
Weighted Average Shares Outstanding (Diluted)
 4.36M 2.65M 1.97M 1.60M 1.09M
Currency in USD

Evelo Biosciences Earnings and Revenue History